Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBI-8000 in Relapsed or Refractory PTCL
NCT02953652Phase 2Completed
- Sponsor
- HUYABIO International, LLC
- Start
- Nov 2016
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of tucidinostat in peripheral T-cell lymphoma (PTCL), sponsored by HUYABIO International, LLC. Started Nov 2016; status: completed.
02
Drugs
tucidinostat
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT02953652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02953652.